InvestorsHub Logo
Followers 6
Posts 88
Boards Moderated 0
Alias Born 03/13/2012

Re: Whoops post# 81662

Wednesday, 12/10/2014 7:25:29 PM

Wednesday, December 10, 2014 7:25:29 PM

Post# of 403091
Working my way through today's post so forgive me if this has already been addressed by a later post.

This was referenced in the 11/24 news release from Leo.

"Looking to Brilacidin, the lead drug candidate in the Company’s definsin-mimetic platform, Cellceutix has signed an agreement with a division of one of the largest U.S. pharmaceutical companies for testing Brilacidin as a component of certain implanted devices as a means to prevent infection. This potential prophylactic use was not part of Cellceutix’s strategic plans for Brilacidin, but given the compilation of clinical and laboratory data, it is a logical application that could potentially add millions of dollars of revenue to the Company. The material transfer does not cover the pharmaceutical use of Brilacidin for treatment of infections or other diseases. A final contract can only be entered into if and when Brilacidin receives Food and Drug Administration (FDA) approval."

- See more at: http://cellceutix.com/cellceutix-december-to-be-momentous-month-in-companys-history/#sthash.pzrmBupe.dpuf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News